Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
39
PharmaCompass offers a list of Elinzanetant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Elinzanetant manufacturer or Elinzanetant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Elinzanetant manufacturer or Elinzanetant supplier.
PharmaCompass also assists you with knowing the Elinzanetant API Price utilized in the formulation of products. Elinzanetant API Price is not always fixed or binding as the Elinzanetant Price is obtained through a variety of data sources. The Elinzanetant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Elinzanetant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elinzanetant, including repackagers and relabelers. The FDA regulates Elinzanetant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elinzanetant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Elinzanetant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Elinzanetant supplier is an individual or a company that provides Elinzanetant active pharmaceutical ingredient (API) or Elinzanetant finished formulations upon request. The Elinzanetant suppliers may include Elinzanetant API manufacturers, exporters, distributors and traders.
click here to find a list of Elinzanetant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Elinzanetant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Elinzanetant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Elinzanetant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Elinzanetant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Elinzanetant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Elinzanetant suppliers with NDC on PharmaCompass.
Elinzanetant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elinzanetant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elinzanetant GMP manufacturer or Elinzanetant GMP API supplier for your needs.
A Elinzanetant CoA (Certificate of Analysis) is a formal document that attests to Elinzanetant's compliance with Elinzanetant specifications and serves as a tool for batch-level quality control.
Elinzanetant CoA mostly includes findings from lab analyses of a specific batch. For each Elinzanetant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elinzanetant may be tested according to a variety of international standards, such as European Pharmacopoeia (Elinzanetant EP), Elinzanetant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elinzanetant USP).
